Goal
Selective destruction of cancer cells by disrupting their glucose metabolism using ultra-high-frequency electromagnetic radiation combined with glucose-blocking agents.
Problem
Cancer (malignant tumor growth).
Concept Summary
The method injects an intravenous solution of oxidised amino-acid compounds (e.g., cystine, oxidised glutathione) that mimic glucose and deliver oxygen to cancer cells. Immediately thereafter, the patient is exposed to 434 MHz electromagnetic radiation for 20-25 minutes. The radiation temporarily forces cancer cells to burn glucose without oxygen, causing metabolic stress and cell death while normal cells are only briefly stimulated to divide for repair.
Principles
- Selective metabolic disruption of cancer cells
- Resonance-induced cellular vibration
- Microwave-frequency electromagnetic activation of glucose oxidation
- Use of oxidised amino-acid analogs as glucose-blocking agents
Scientific Domains
Materials
- cystine
- oxidised glutathione
- penicillamine disulfide
- cysteine sulfoxide
- sulfoximine
- sulfonic compounds
Mechanisms of Action
- 434 MHz radiation temporarily activates glucose burning in cancer cells without oxygen
- Oxidised cystine/glutathione act as glucose analogs, delivering oxygen and causing metabolic overload
- Resonance vibration of cancer cells ("shaking like a bell") enhances uptake of the blocking agent
Energy Sources
Applications
- Cancer treatment
- Potential adjunct for viral or autoimmune conditions (as per patent abstracts)
Claimed Performance
In a series of 15 treatments over three weeks, patients showed 10-20 % reduction in tumor mass; a mesothelioma patient remained disease-free after seven treatment courses.
Experimental Evidence
Results reported from 15 treatments over three weeks; anecdotal case of a mesothelioma patient alive after seven courses. No peer-reviewed clinical trial data provided.
Replication Status
No independent replication or peer-reviewed study mentioned.
Limitations
- Requires intravenous access and a PICC line for some patients
- Contraindicated in thalassaemia, recent chemotherapy, fluid collections (ascites, pleural effusion), and smokers
- Side-effects include mild warming and occasional transient brain-glucose deprivation
- Efficacy data limited to small, non-controlled case series
Red Flags
- Lack of peer-reviewed clinical trial data
- Reliance on anecdotal case reports
- Potential for unproven claims of cure
- Use of non-standard medical terminology (e.g., "UHF creates resonance like a bell")
